Previous 10 | Next 10 |
Sonoma Pharmaceuticals (SNOA) +28% on agreement with EMC pharma.Future FinTech Group (FTFT) +24% on acquiring bitcoin mining farm.AeroCentury (ACY) +22%.Jaguar Health (JAGX) +19% on FY results.P&F Industries (PFIN) +21%.AgEagle Aerial Systems (UAVS) +19% on FY results....
VirTra (VTSI) +56% on Q4 results.Color Star Technology Co., Ltd. (CSCW) +56% as company to develop NFT.Performant Financial Corporation (PFMT) +26%.Monopar Therapeutics (MNPR) +18% on preclinical update of its uPA.Moleculin Biotech (MBRX) +18% on FDA's fast track desi...
AbCellera Biologics, Inc. (ABCL) Q4 2020 Earnings Conference Call March 29, 2021 5:00 PM ET Company Participants Tryn Stimart – Chief Legal Officer, Chief Compliance Officer and Corporate Secretary Carl Hansen – President and Chief Executive Officer Andrew Booth – Chief F...
AbCellera Biologics (ABCL) has added more than a tenth in the post-market after its 2020 revenue came ahead of expectations thanks to the boost in royalty revenue.Total revenue for the year reached $233.2M up ~1,907.9% as research fees increased ~70.9% YoY with royalty revenue makin...
Gainers: [[SEAC]] +30.3%. [[ABCL]] +13.7%. [[VSTM]] +9.7%. [[GIII]] +9.5%. [[RRR]] +8.8%.Losers: [[WVE]] -24.8%. [[SCPH]] -15.4%. [[PCVX]] -12%. [[UPC]] -9.5%. [[TDUP]] -6%. For further details see: VSTM, WVE, ABCL and SCPH among after-hours movers
AbCellera Biologics (ABCL): FY GAAP EPS of $0.45 misses by $0.14.Revenue of $233.15M (+1908.2% Y/Y) beats by $23.83M.Cash and cash equivalents of $594.1MShares +4.12%.Press Release For further details see: AbCellera Biologics EPS misses by $0.14, beats on revenue
Total revenue of $233 million 1 in 2020, up 1,908% year-over-year Total revenue from research fees of $20 million, up 71% year-over-year Total programs under contract of 103, up 72% year-over-year EPS of $0.53 (basic) and $0.45 (diluted) compared to $...
Halvorsen's 13F portfolio value increased from $27.68B to $36.37B. The number of positions increased from 86 to 96. Viking Global added UnitedHealth, AbCellera Biologics, Walt Disney, and Palo Alto Networks while dropping Analog Devices, CME Group, Comcast, and Exact Sciences. The...
Finding the next Amazon is the holy grail and an epic quest for any growth oriented investor. The reality however is that the journey to that goal is primarily littered with shattered portfolios and broken dreams. I am taking a slightly different approach. By picking trends poised...
The tech selloff so far has been brutal and quick, with 5% to 10% moves daily in high growth names across the board. On February 23rd I published a list of my picks to buy on weakness and I acted on it, in some cases it appears too early. Below I list which companies I purchased d...
News, Short Squeeze, Breakout and More Instantly...
AbCellera Biologics Inc. Company Name:
ABCL Stock Symbol:
NASDAQ Market:
AbCellera Biologics Inc. Website:
AbCellera (Nasdaq: ABCL) will announce its second quarter 2024 financial results on Tuesday, August 6, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day. A live audio webcast of the earnings conference may be accessed through a link t...
2024-06-13 05:40:00 ET Discovering new drugs can be a lucrative endeavor, but things aren't working out lately for AbCellera Biologics (NASDAQ: ABCL) . Shares of this unusual biotech stock are down by about 57% from the high water mark they set last summer. The steep losses migh...
AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024, at 12:20 p.m. Pacific Time (3:20 p.m. Eastern Time). A live audio webcast of the presentation may be accessed throug...